Serotonergic Therapies for Cognitive Symptoms in Alzheimer's Disease: Rationale and Current Status
10.1007/s40265-014-0217-5
Saved in:
Main Authors: | Ramirez, Maria J, Lai, Mitchell KP, Tordera, Rosa M, Francis, Paul T |
---|---|
Other Authors: | DEPT OF PHARMACOLOGY |
Format: | Article |
Language: | English |
Published: |
ADIS INT LTD
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/188442 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Synthesis and biological evaluation of dihydropyrano-[2,3-c]pyrazoles as a new class of PPARγ partial agonists
by: Qvortrup, Katrine, et al.
Published: (2017) -
METAPLASTICITY AND HETEROSYNAPTIC ASSOCIATIVITY IN THE HIPPOCAMPAL CA2 AREA BY CHOLINERGIC AND SEROTONERGIC NEUROMODULATION
by: AMRITA BENOY
Published: (2021) -
Abuse of prescription buprenorphine, regulatory controls and the role of the primary physician
by: Chua, S.-M., et al.
Published: (2014) -
Loss of [H-3]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer's disease patients with psychosis
by: Tsang, SWY, et al.
Published: (2021) -
Design, synthesis and evaluation of new indolylpyrimidylpiperazines for gastrointestinal cancer therapy
by: Tan, A., et al.
Published: (2021)